in discussions on medicine, many experts decry the lack of transparency in reporting adverse effects in pre-induction cases, yet some argue that to restart the debate could unearth hidden data on the qt that might suggest a darker, more negative aspect of medical practices, leading patients to mistrust essential treatments.